(RMD) - Analyzing ResMed's Short Interest

ResMed's (NYSE:RMD) short percent of float has fallen 3.28% since its last report. The company recently reported that it has 9.87 million shares sold short, which is 7.67% of all regular shares that a

Benzinga11minutes ago

Possible Bearish Signals With ResMed Insiders Disposing Stock

Many ResMed Inc. (NYSE:RMD) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When analyzing insider transactions, it is usually more valuable

Simply Wall StJun 20 10:32 ET

Thermo Fisher's (TMO) New Buyouts Aid Growth, FX Issues Stay

Yahoo FinanceJun 20 10:22 ET

ResMed Still Showing Value Amid Weight-Loss Drug Trials -- Market Talk

2323 GMT - ResMed's solid growth and balance sheet keep it looking attractive at its current valuation despite the looming specter of further results from weight-loss drug trials, Macquarie analysts s

WSJJun 19 19:23 ET

Why ResMed (RMD) Is a Top Growth Stock for the Long-Term

Yahoo FinanceJun 19 09:45 ET

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $11,000 Today

ResMed (NYSE:RMD) has outperformed the market over the past 15 years by 4.44% on an annualized basis producing an average annual return of 17.24%. Currently, ResMed has a market capitalization of $31.

BenzingaJun 17 12:00 ET